The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study
Open accessAbstract
OBJECTIVES: To determine whether the receipt of chemotherapy among terminally ill cancer patients months before death was associated with patients' subsequent intensive medical care and place of death. DESIGN: Secondary analysis of a prospective, multi-institution, longitudinal study of patients with advanced cancer. SETTING: Eight outpatient oncology clinics in the United States. PARTICIPANTS: 386 adult patients with metastatic cancers refractory to at least one chemotherapy regimen, whom physicians identified as terminally ill at study enrollment and who subsequently died. PRIMARY OUTCOMES: intensive medical care (cardiopulmonary resuscitation, mechanical ventilation, or both) in the last week of life and patients' place of death (for example, intensive care unit). SECONDARY OUTCOMES: survival, late hospice referrals (≤ 1 week before death), and dying in preferred place of death. RESULTS: 216 (56%) of 386 terminally ill cancer patients were receiving palliative chemotherapy at study enrollment, a median of 4.0 months before death. After propensity score weighted adjustment, use of chemotherapy at enrollment was associated with higher rates of cardiopulmonary resuscitation, mechanical ventilation, or both in the last week of life (14% v 2%; adjusted risk difference 10.5%, 95% confidence interval 5.0% to 15.5%) and late hospice referrals (54% v 37%; 13.6%, 3.6% to 23.6%) but no difference in survival (hazard ratio 1.11, 95% confidence interval 0.90 to 1.38). Patients receiving palliative chemotherapy were more likely to die in an intensive care unit (11% v 2%; adjusted risk difference 6.1%, 1.1% to 11.1%) and less likely to die at home (47% v 66%; -10.8%, -1.0% to -20.6%), compared with those who were not. Patients receiving palliative chemotherapy were also less likely to die in their preferred place, compared with those who were not (65% v 80%; adjusted risk difference -9.4%, -0.8% to -18.1%). CONCLUSIONS: The use of chemotherapy in terminally ill cancer patients in the last months of life was associated with an increased risk of undergoing cardiopulmonary resuscitation, mechanical ventilation or both and of dying in an intensive care unit. Future research should determine the mechanisms by which palliative chemotherapy affects end of life outcomes and patients' attainment of their goals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000678 · Cited by 7,482
You want to measure coping but your protocol’ too long: Consider the brief cope
Carver, C. S. (1997) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm0401_6 · Cited by 7,361
Reducing Bias in Observational Studies Using Subclassification on the Propensity Score
Rosenbaum, P. R., & Rubin, D. B. (1984) · Journal of the American Statistical Association · doi:10.1080/01621459.1984.10478078 · Cited by 3,082
Wright, A. A. (2008) · JAMA · doi:10.1001/jama.300.14.1665 · Cited by 2,788
Self-citationFamily Perspectives on End-of-Life Care at the Last Place of Care
Teno, J. M. (2004) · JAMA · doi:10.1001/jama.291.1.88 · Cited by 1,490
Relationship between cancer patients' predictions of prognosis and their treatment preferences
Weeks, J. C. (1998) · JAMA · doi:10.1001/jama.279.21.1709 · Cited by 1,319
Self-citationPatients’ expectations about effects of chemotherapy for advanced cancer
Weeks, J. C., Catalano, P. J., Cronin, A., Finkelman, M. D., Mack, J. W., Keating, N. L., & Schrag, D. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204410 · Cited by 1,149
Self-citationTrends in the Aggressiveness of Cancer Care Near the End of Life
Earle, C. C., Neville, B. A., Landrum, M. B., Ayanian, J. Z., Block, S. D., & Weeks, J. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.136 · Cited by 987
Self-citationFactors influencing death at home in terminally ill patients with cancer: systematic review
Gomes, B., & Higginson, I. J. (2006) · BMJ · doi:10.1136/bmj.38740.614954.55 · Cited by 973
Teno, J. M., Gozalo, P. L., Bynum, J. P. W., Leland, N. E., Miller, S. C., Morden, N. E., Scupp, T., Goodman, D. C., & Mor, V. (2013) · JAMA · doi:10.1001/jama.2012.207624 · Cited by 966
Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue?
Earle, C. C., Landrum, M. B., Souza, J. M., Neville, B. A., Weeks, J. C., & Ayanian, J. Z. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8253 · Cited by 949
Self-citationWright, A. A., Keating, N. L., Balboni, T. A., Matulonis, U. A., Block, S. D., & Prigerson, H. G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3863 · Cited by 797
Self-citationSlevin, M. L., Stubbs, L., Plant, H. J., Wilson, P., Gregory, W. M., Armes, P. J., & Downer, S. M. (1990) · BMJ · doi:10.1136/bmj.300.6737.1458 · Cited by 753
Schnipper, L. E., Smith, T. J., Raghavan, D., Blayney, D. W., Ganz, P. A., Mulvey, T. M., & Wollins, D. S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.8375 · Cited by 649
Greer, J. A., Pirl, W. F., Jackson, V. A., Muzikansky, A., Lennes, I. T., Heist, R. S., Gallagher, E. R., & Temel, J. S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.7996 · Cited by 574
Silvestri, G., Pritchard, R., & Welch, H. G. (1998) · BMJ · doi:10.1136/bmj.317.7161.771 · Cited by 433
Matsuyama, R., Reddy, S., & Smith, T. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6236 · Cited by 403
Physician factors associated with discussions about end‐of‐life care
Keating, N. L., Landrum, M. B., Rogers, S. O., Baum, S. K., Virnig, B. A., Huskamp, H. A., Earle, C. C., & Kahn, K. L. (2010) · Cancer · doi:10.1002/cncr.24761 · Cited by 345
Self-citationChemotherapy Use among Medicare Beneficiaries at the End of Life
Emanuel, E. J., Young-Xu, Y., Levinsky, N. G., Gazelle, G., Saynina, O., & Ash, A. S. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-8-200304150-00011 · Cited by 317
A multiple imputation strategy for clinical trials with truncation of patient data
Lavori, P. W., Dawson, R., & Shera, D. (1995) · Statistics in Medicine · doi:10.1002/sim.4780141707 · Cited by 291
The Role of Chemotherapy at the End of Life: “When Is Enough, Enough?”
Harrington, S. E., & Smith, T. J. (2008) · JAMA · doi:10.1001/jama.299.22.2667 · Cited by 280
Propensity score weighting with multilevel data
Li, F., Zaslavsky, A. M., & Landrum, M. B. (2013) · Statistics in Medicine · doi:10.1002/sim.5786 · Cited by 256
Resurrecting Treatment Histories of Dead Patients: A Study Design That Should Be Laid to Rest
Bach, P. B., Schrag, D., & Begg, C. B. (2004) · JAMA · doi:10.1001/jama.292.22.2765 · Cited by 255
Kelley, A. S., Deb, P., Du, Q., Aldridge Carlson, M. D., & Morrison, R. S. (2013) · Health Affairs · doi:10.1377/hlthaff.2012.0851 · Cited by 231
Morden, N. E., Chang, C.-H., Jacobson, J. O., Berke, E. M., Bynum, J. P. W., Murray, K. M., & Goodman, D. C. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.0650 · Cited by 215
Mack, J. W., Block, S. D., Nilsson, M., Wright, A., Trice, E., Friedlander, R., Paulk, E., & Prigerson, H. G. (2009) · Cancer · doi:10.1002/cncr.24360 · Cited by 182
Self-citationPatient centered decision making in palliative cancer treatment: a world of paradoxes
de Haes, H., & Koedoot, N. (2003) · Patient Education and Counseling · doi:10.1016/s0738-3991(03)00079-x · Cited by 168
Necessary Collusion: Prognostic Communication With Advanced Cancer Patients
Helft, P. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.003 · Cited by 164
Sulmasy, D. P., Astrow, A. B., He, M. K., Seils, D. M., Meropol, N. J., Micco, E., & Weinfurt, K. P. (2010) · Cancer · doi:10.1002/cncr.25201 · Cited by 158
The effect on survival of continuing chemotherapy to near death
Saito, A. M., Landrum, M. B., Neville, B. A., Ayanian, J. Z., & Earle, C. C. (2011) · BMC Palliative Care · doi:10.1186/1472-684x-10-14 · Cited by 157
Buiting, H. M., Rurup, M. L., Wijsbek, H., van Zuylen, L., & den Hartogh, G. A. (2011) · BMJ Supportive & Palliative Care · doi:10.1136/bmj.d1933 · Cited by 154
Alonso‐Babarro, A., Bruera, E. D., Varela-Cerdeira, M., Boya-Cristia, M. J., Madero, R., Vigil, I. T., de Castro, J., & González-Barón, M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6752 · Cited by 145
Discussions With Physicians About Hospice Among Patients With Metastatic Lung Cancer
Huskamp, H. A., Keating, N. L., Malin, J. L., Zaslavsky, A. M., Weeks, J. C., Earle, C. C., Teno, J. M., Virnig, B. A., Kahn, K. L., He, Y., et al. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.127 · Cited by 129
Self-citationHospices’ Enrollment Policies May Contribute To Underuse Of Hospice Care In The United States
Carlson, M. D. A., Barry, C. L., Cherlin, E. J., McCorkle, R. C., & Bradley, E. H. (2012) · Health Affairs · doi:10.1377/hlthaff.2012.0286 · Cited by 113
Why do our patients get chemotherapy until the end of life?
Braga, S. A. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr416 · Cited by 111
Prigerson, H. G. (1992) · Journal of Health and Social Behavior · doi:10.2307/2137315 · Cited by 101
Self-citationTreatment Preferences in Recurrent Ovarian Cancer
Donovan, K. A., Greene, P. G., Shuster, J. L., Partridge, E. E., & Tucker, D. C. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6748 · Cited by 95
Letting Go of the Rope — Aggressive Treatment, Hospice Care, and Open Access
Wright, A. A., & Katz, I. T. (2007) · New England Journal of Medicine · doi:10.1056/nejmp078074 · Cited by 88
Self-citationCarlson, M. D. A., Herrin, J. S., Du, Q., Epstein, A. J., Barry, C. L., Morrison, R. S., Back, A. L., & Bradley, E. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.1818 · Cited by 86
Kiani, R., Hanks, T. D., & Shadlen, M. N. (2006) · Nature Neuroscience · doi:10.1038/nn0706-861 · Cited by 81
Teno, J. M., Casarett, D., Spence, C., & Connor, S. R. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.05.012 · Cited by 75
Jeurkar, N., Farrington, S., Craig, T. R., Slattery, J., Harrold, J. K., Oldanie, B., Teno, J. M., & Casarett, D. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5711 · Cited by 63
Assessment of Patient Preferences: Integrating Treatments and Outcomes
Fried, T. R., Bradley, E. H., & Towle, V. R. (2002) · The Journals of Gerontology Series B · doi:10.1093/geronb/57.6.s348 · Cited by 63
Determining the extent of the cancer and clinical planning for cure
Karnofsky, D. A. (1968) · Cancer · doi:10.1002/1097-0142(196810)22:4<730::aid-cncr2820220407>3.0.co;2-h · Cited by 48
Cavalli‐Björkman, N., Glimelius, B. L. G., & Strang, P. M. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001248 · Cited by 27
Anders, C. K., & Peppercorn, J. M. (2009) · Cancer Investigation · doi:10.1080/07357900802484944 · Cited by 11
(2000) · doi:10.1002/(sici)1097-4679(200004)56:4<519::aid-jclp6>3.0.co;2-1
Cited by
Communication About Serious Illness Care Goals: A Review and Synthesis of Best Practices
Bernacki, R. E., & Block, S. D. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.5271 · Cited by 1,422
Integration of oncology and palliative care: a Lancet Oncology Commission
Kaasa, S., Loge, J. H., Aapro, M., Albreht, T., Anderson, R., Bruera, E., Brunelli, C., Caraceni, A., Cervantes, A., Currow, D. C., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30415-7 · Cited by 830
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
Prigerson, H. G., Bao, Y., Shah, M. A., Paulk, M. E., LeBlanc, T. W., Schneider, B. J., Garrido, M. M., Reid, M. C., Berlin, D. A., Adelson, K. B., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2378 · Cited by 645
Self-citationHui, D., Hannon, B. L., Zimmermann, C., & Bruera, E. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21490 · Cited by 430
Family Perspectives on Aggressive Cancer Care Near the End of Life
Wright, A. A., Keating, N. L., Ayanian, J. Z., Chrischilles, E. A., Kahn, K. L., Ritchie, C. S., Weeks, J. C., Earle, C. C., & Landrum, M. B. (2016) · JAMA · doi:10.1001/jama.2015.18604 · Cited by 424
Self-citation
Metadata
- Authors
- Wright, A. A., Zhang, B., Keating, N. L., Weeks, J. C., & Prigerson, H. G.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2014-03-04
- Volume
- 348
- Issue
- mar04 4
- Pages
- g1219-g1219
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2023888294
- Cited by
- 340
- References
- 49
- FWCI
- 38.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.